Avosentan reduces albumin excretion in diabetics with macroalbuminuria.
Wenzel RR, Littke T, Kuranoff S, Jürgens C, Bruck H, Ritz E, Philipp T, Mitchell A; SPP301 (Avosentan) Endothelin Antagonist Evaluation in Diabetic Nephropathy Study Investigators.
Wenzel RR, et al.
J Am Soc Nephrol. 2009 Mar;20(3):655-64. doi: 10.1681/ASN.2008050482. Epub 2009 Jan 14.
J Am Soc Nephrol. 2009.
PMID: 19144760
Free PMC article.
Clinical Trial.